Reimagining AHR in Cancer: From Environmental Sensor to Novel Immunomodulatory Therapeutic Target
International Journal of Biological Sciences · 29.05.2026 · 22 (11) · 5822-5851
DOI: 10.7150/ijbs.129455 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, erschienen am 29.05.2026. Verfasst von Yuanhao Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Cancer Metabolism, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospit…. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The aryl hydrocarbon receptor (AHR) is an environmental sensor in mammals and a ligand-dependent, highly conserved transcription factor. It belongs to the basic helix-loop-helix family of transcription factors and is the only known ligand-activated member within this family. Previous studies have revealed its significant roles in physiological regulation, metabolic homeostasis, and tumorigenesis. AHR governs transcriptional regulation and epigenetic modifications through diverse mechanisms and plays an important role in various types of cancer. In this review, we introduce the history and structure of AHR and summarize its modes of action via canonical and non-canonical pathways. We elaborate on the distinct impact of AHR on mitochondrial metabolism, epigenetics, as well as cell death and fate. Furthermore, we systematically discuss the relationship between AHR and tumor immunity. Finally, we explore the prospects of AHR in the tumor microenvironment, cancer immunity and therapy, and its potential as an immunotherapeutic target, along with current achievements in drug development targeting AHR. These research findings may provide insights into the relationship between AHR and its regulated molecules and pathways in cancer, as well as mechanisms for cancer treatment and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Key Laboratory of Cancer Metabolism, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism Changsha, 410013, Hunan,…
- NHC Key Laboratory of Carcinogenesis, Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, 410078, Hunan, China.
- Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
- Department of Oncology, Institute of Medical Sciences, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
- Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Zitieren
APA
Peng, Y., Zhao, Y., Zhou, Y., Liu, S., Xiao, D., & Tao, Y. (2026). Reimagining AHR in Cancer: From Environmental Sensor to Novel Immunomodulatory Therapeutic Target. International Journal of Biological Sciences, 22(11), 5822-5851. https://doi.org/10.7150/ijbs.129455
Vancouver
Peng Y, Zhao Y, Zhou Y, Liu S, Xiao D, Tao Y. Reimagining AHR in Cancer: From Environmental Sensor to Novel Immunomodulatory Therapeutic Target. International Journal of Biological Sciences. 2026;22(11):5822-5851. doi:10.7150/ijbs.129455
BibTeX
@article{Peng2026,
author = {Peng, Yuanhao and Zhao, Yaxin and Zhou, Yangying and Liu, Shuang and Xiao, Desheng and Tao, Yongguang},
title = {Reimagining AHR in Cancer: From Environmental Sensor to Novel Immunomodulatory Therapeutic Target},
journal = {International Journal of Biological Sciences},
year = {2026},
volume = {22},
number = {11},
pages = {5822--5851},
doi = {10.7150/ijbs.129455}
}
EUVIMED